Skip to main content
. Author manuscript; available in PMC: 2021 Apr 9.
Published in final edited form as: Gastroenterology. 2020 Oct 1;160(1):183–192.e3. doi: 10.1053/j.gastro.2020.09.038

Table 2.

Fecal Microbiota Transplantation Indication and Related Characteristics

Characteristics n (%)
FMT indication
CDI 259 (100)
Method of CDI diagnosis
Symptoms and PCR 163 (63)
Symptoms and EIA 54 (21)
Symptoms, EIA and PCR 20 (8)
Symptoms only 12 (5)
PCR only 8 (3)
EIA only 1 (<1)
Not reported 1 (<1)
CDI severity
Mild 92 (36)
Moderate 115 (44)
Severe 48 (19)
Severe-complicated 2 (1)
Not reported 2 (1)
CDI duration
<1 mo 14 (5)
1–6 mo 149 (58)
7–12 mo 61 (24)
13–24 mo 17 (7)
>24 mo 16 (6)
Not reported 2 (1)
No. of prior CDI episodes
1 15 (6)
2 34 (13)
3 110 (42)
4 56 (22)
5 or more 42 (16)
Not reported 2 (1)
Prior treatments for CDI
Vancomycin 236 (91)
Vancomycin taper/pulse 141 (54)
Metronidazole 104 (40)
Fidaxomicin 73 (28)
Probiotics 44 (17)
Other treatments 14 (5)
No prior treatments 5 (2)

EIA, enzyme immunoassay; PCR, polymerase chain reaction.